Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CLIAC Seeks Role In FDA's Revision Of Lab Test Waiver Policy

This article was originally published in The Gray Sheet

Executive Summary

The Clinical Laboratory Improvement Advisory Committee (CLIAC) requests that FDA postpone guidance or rulemaking on CLIA waiver applications until it makes recommendations on the issue at a February or March 2001 meeting.

You may also be interested in...



GHTF Pilot Update: Japan Joins In, US/Canada To Coordinate Parallel Reviews

FDA's existing joint review program with Canada could be a vehicle for the agency to conduct parallel reviews of cardiovascular devices using the Global Harmonization Task Force's common premarket submission format

GHTF Pilot Update: Japan Joins In, US/Canada To Coordinate Parallel Reviews

FDA's existing joint review program with Canada could be a vehicle for the agency to conduct parallel reviews of cardiovascular devices using the Global Harmonization Task Force's common premarket submission format

HHS Sign-Off Critical To CLIA Waiver Proposal: FDA Criteria At Odds With CMS'

Manufacturers seeking CLIA waivers for in vitro diagnostics should wait until FDA's interim guidance is finalized before using the alternative approach it outlines, according to CDRH.

Related Content

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel